The Reports

Umbilical Clamp or Similar

Written by The Zewski Report | Jun 22, 2025 3:47:13 AM

Although this report focuses on the development of an Umbilical Clamp, the insights and methodology are broadly relevant to a wide range of similar medical devices providing general principles and realistic planning assumptions to guide innovators through the development landscape—especially for devices that might appear simple but involve hidden complexities.

The assessment is based on our understanding of typical product development pathways and the points at which clients usually engage with us. In cases where specific project details were unavailable, we have provided informed projections to aid strategic planning.

FDA Identification

An obstetric-gynecologic specialized manual instrument is one of a group of devices used during obstetric-gynecologic procedures to perform manipulative diagnostic and surgical functions (e.g., dilating, grasping, measuring, and scraping), where structural integrity is the chief criterion of device performance. 

General Description

The umbilical clamp is a small, handheld, single-use device used immediately after childbirth to securely close off the newborn's umbilical cord, preventing blood loss and infection. Typically made of medical-grade plastic, the clamp is placed about one inch from the infant’s abdomen and snapped shut, providing a mechanical seal on the cord until natural drying and detachment occur. The clamp remains attached for several days until the cord stump naturally falls off.

This type of clamp falls under the FDA's definition of an obstetric-gynecologic specialized manual instrument. These instruments are typically non-powered and are used in procedures that involve grasping, clamping, or manipulating tissue—making structural integrity the primary criterion for device performance. In the case of the umbilical clamp, that means it must consistently exert and maintain a safe, uniform pressure, regardless of handling variation or environmental conditions in the delivery setting.

Because it is small, plastic, and non-electronic, the umbilical clamp represents one of the most structurally simple and widely adopted devices in neonatal care—but even simple devices must meet key clinical and manufacturing criteria. Clamps must be sterile, biocompatible, easily handled by gloved hands, and disposable to reduce infection risk.

Strategic Takeaway

While the umbilical clamp is a structurally simple, moderate-risk Class II device, its widespread use and critical role in immediate postnatal care mean it must be engineered for absolute reliability, ease of use, and consistent manufacturability. Despite its 510(k) exemption, full compliance with design controls and quality regulations is required. Getting these elements right early ensures product safety, regulatory readiness, and a clear path to commercialization.

The current umbilical clamp project is in the concept phase, supported by a granted patent in one country, but without prior iterations, formal documentation, or technical validation. This early-stage status offers a rare window of flexibility—there’s still time to refine the concept, assess manufacturability, and align product features with clinical user needs before resources are committed to prototyping or regulatory engagement.

Where You Are in the Development Journey

At this point, your project is:

  • Handheld and portable, aligning with typical clinical workflows in labor and delivery.
  • Simple in materials and structure, made entirely of plastic with no moving parts or electronics.
  • Intended for single-use, therapeutic application, contacting only external tissue (umbilical cord stump).
  • Envisioned with a basic supply chain, relying largely on off-the-shelf materials.

However, design for manufacturing (DFM) has not yet been considered. While this is common at the concept stage, overlooking DFM too long can lead to expensive rework down the road. It’s also worth noting that the project does not yet have clinical or institutional support, which can slow user feedback collection and limit early traction.

What Makes This Project Unique

Despite its simplicity, the device is slightly unique in functionality—this might reflect a novel clamp geometry, a more secure locking mechanism, or user-centric ergonomic enhancements. The granted patent indicates that at least one innovative feature has been recognized, which is a major asset moving forward.

Also worth noting: unlike high-tech or software-driven devices, this clamp project is unencumbered by power systems, firmware updates, or battery testing. That removes entire categories of cost and risk.

What Lies Ahead

With a product that is:

  • Structurally simple,
  • Conceptually validated (via patent),
  • Moderate-risk but 510(k)-exempt (Class II),
you’re in a strong position to begin feasibility planning and prototyping. However, because the device now requires design controls, your next milestones should include:
  • Locking down a manufacturable design,
  • Running basic benchtop performance tests,
  • Gathering clinician input, and
  • Starting a design history file to comply with 21 CFR Part 820.

These steps will help evolve your concept into a safe, effective, and commercially viable medical device.

Strategic Takeaway

This is a textbook case of a low-risk medical product with clear utility and manageable complexity—but don’t let its simplicity create complacency. Successful products depend not just on ideas or patents, but on practical, validated execution that anticipates clinical realities and manufacturing needs.